NCT05326308 2025-09-23
ARIADNE
iOMEDICO AG
Recruiting
Clinical Trials
4 trialsNCT03374137 2023-01-12
Observational Study to Monitor Safety and Effectiveness of Obinutuzumab in Follicular Lymphoma or Previously Untreated Chronic Lymphocytic Leukemia
Hoffmann-La Roche
Completed
NCT02915224 2022-06-28
A Study of Obinutuzumab Evaluating Efficacy, Safety and Cost of Disease Management in Participants With Chronic Lymphocytic Leukemia and Comorbidities
Hoffmann-La Roche
Completed
NCT03059251 2020-04-17
Observational Study: Safety and Effectiveness of Obinutuzumab in Chronic Lymphocytic Leukemia in Argentina
Hoffmann-La Roche
Completed